Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2006-08-15
2006-08-15
Prouty, Rebecca E. (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C530S350000, C514S012200, C424S094500, C536S023500
Reexamination Certificate
active
07091021
ABSTRACT:
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. Catalytically active and inactive human telomerase reverse transcriptase variants comprising deletions or other mutations are provided.
REFERENCES:
patent: 6261556 (2001-07-01), Weinrich et al.
patent: 6261836 (2001-07-01), Cech et al.
patent: 6846662 (2005-01-01), Kilian et al.
patent: 6916642 (2005-07-01), Kilian et al.
patent: WO 98/07838 (1998-02-01), None
patent: WO 98/21343 (1998-05-01), None
patent: WO 98/37181 (1998-08-01), None
patent: WO 99/01560 (1999-01-01), None
Molecular Biology and Biotechnology. A Comprehensive Desk Reference, Meyers R. ed. Wiley-VCH, New York 1995, p. 187.
Leem et al., The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions, Oncogene, 2002, 21, 769-777.
Li H. et al. Protein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Brest Cancer Cells, J. Biol. Chem, 1997, 272, 16729-16732.
Bachand et al., Functional Regions of Human Telomerse Reverse Transcriptase and Human Telomerase RNA Required for Telomerase Activity and RNA-Protein Interactions, Mol. and Cellular Biol. 21:1888 (2001).
Bodnar et al., Extension of Life-span by Induction of Telomerase into Normal Human Cells, Science 279:349 (1998).
Bryan et al., A Mutant ofTetrahymenaTelomerase Reverse Transcriptase with Increased Processivity, J. Biol. Chem. 275:24199 (2000).
Bryan et al., Telomerase RNA Bound by Protein Notifs Specific to Telomerase Reverse Transcriptase, Molecular Cell 6:493 (2000).
Bryan et al., Telomerase reverse transcriptase genes identified inTetrahymena thermophilaandOxytricha trifallax, Pro. Natl. Acad. Sci. USA 95:8479 (1998).
Colgin et al., The hTERTapha splice variant is a dominant negative inhibitor of telomerase activity, Neoplasia 2:426 (2000).
Farmery et al., Major Histocompatability Class I Folding, Assembly, and Degradation: A Paradigm for Two-Stage Quality Control in the Endoplasmic Reticulum, Progress in Nucleic Acid Res. 67:235 (2001).
Freidman et al., Essential functions of amino-terminal domains in the yeast telomerase catalytic subunit revealed by selection for variable mutants, Genes & Dev. 13:2863 (1999).
Haering et al., Analysis of telomerase catalytic subunit mutantsin vivoandIn vitroinSchizosaccharomyces pombe, PNAS 97:6367 (2000).
Hahn et al., Inhibition of telomerase limits the growth of human cancer cells, Nature Medicine 5:1164 (1999).
Harrington et al., Human telomerase contians evolutionarily consderved catalytic and structural subunits, Genes Dev. 11:3109 (1997).
Killan et al., Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types, Hum. Mol. Genet. 6:2011 (1997).
Lai et al., RNA Binding Domain of Telomerase Reverse Transcriptase, Mol. and Cellular Biol. 21:990 (2001).
Lingner et al., Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase, Science 276:561 (1997).
Morin, The Implications of Telomerase Biochemistry for Human Disease, Eur. J. Biol. Chem. 33:750(1998).
Myerson et al., hEST2, the Putative Human Telomerase Catalytic Subunit Gene Is Up-Regulated in Tumor Cells and during Immortalization, Cell 90:785 (1997).
Nakamura et al., Telomerase Catalytic Subunit Homologs from Fission Yeast and Human, Science 277:955 (1997).
Perez et al., Human formyl peptide receptor ligand binding domain(s). Studies using an improved mutagenesis/expression vector reveal a novel mechanism for the regulation of receptor occupancy, J. Biol. Chem. 269:22485 (1994).
Solheim et al., Class I MHC molecules: assembly and antigen presentation, Immun. Reviews 172:11 (1999).
Weinrich et al., Reconstitution of Human Telomerase with the Template RNA Component hTR and the Catalytic Protein Subunit hTRT, Nat. Genet. 17:498 (1997).
Xia et al., Identificationof Funtionally Important Domains in the N-Terminal Region of Telomerase Reverse Transcriptase, Mod. and Cellular Biol. 20:5196 (2000).
Zakharova et al., Structural Constraints in the HIV-1 Reverse Transcriptase-Primer/Template Complex for the Initiation of DNA Synthesis from Primer tRNALys3, Biochem. 37:13343 (1998).
Earp David J.
Geron Corporation
Prouty Rebecca E.
Schiff J. Michael
Walicka Malgorzata A.
LandOfFree
Inactive variants of the human telomerase catalytic subunit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactive variants of the human telomerase catalytic subunit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactive variants of the human telomerase catalytic subunit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712853